FILING ANALYSIS · TUESDAY, OCTOBER 27
Pulmonx Corp LUNG — 8-K: Results of Operations and Financial Condition
positive
Pulmonx Corp reported a 6% year-over-year increase in revenue to $22.8 million, with a gross margin of 76% and a net loss reduction of 40% to $8.4 million, demonstrating operating leverage from cost realignment efforts. The company also reaffirmed its full-year 2026 revenue guidance of $90-92 million.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →